Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
2.450
+0.220 (9.87%)
At close: Dec 26, 2025, 4:00 PM EST
2.404
-0.046 (-1.87%)
After-hours: Dec 26, 2025, 7:34 PM EST
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $201.87 million as of December 26, 2025. Its market cap has increased by 158.34% in one year.
Market Cap
201.87M
Enterprise Value
164.77M
1-Year Change
158.34%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $201.87M, a decrease of -74.97%. That is a compound annual growth rate of -23.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 183.75M | 89.96% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | 3.03B | 276.02% |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |